TY - JOUR
T1 - Ceftolozane-tazobactam for the treatment of ventilator-associated infections by colistin-resistant Pseudomonas aeruginosa
AU - Lerma, Francisco Álvarez
AU - Bermudez, Rosana Muñoz
AU - Grau, Santiago
AU - Arnillas, María Pilar Gracia
AU - Sorli, Luisa
AU - Recasens, Lluis
AU - García, Miquel Mico
PY - 2017/6/1
Y1 - 2017/6/1
N2 - © 2017, Sociedad Espanola de Quiminoterapia. All rights reserved. The use of colistin for the treatment of multiresistant bacteria has led to the emergence of colistin-resistant strains of Gram-negative bacilli. Treatment of infections caused by these pan–drug-resistant bacteria is difficult owing to the paucity of effective antibiotics. We report two cases of ventilator-associated respiratory infection caused by pan–drug-resistant, colistin-resistant Pseudomonas aeruginosa that were successfully treated with ceftolozane-tazobactam.
AB - © 2017, Sociedad Espanola de Quiminoterapia. All rights reserved. The use of colistin for the treatment of multiresistant bacteria has led to the emergence of colistin-resistant strains of Gram-negative bacilli. Treatment of infections caused by these pan–drug-resistant bacteria is difficult owing to the paucity of effective antibiotics. We report two cases of ventilator-associated respiratory infection caused by pan–drug-resistant, colistin-resistant Pseudomonas aeruginosa that were successfully treated with ceftolozane-tazobactam.
KW - Ceftolozane-tazobactam
KW - Colistin-resistant pseudomonas aeruginosa
KW - ICU
KW - Ventilator-associated respiratory infection
M3 - Article
VL - 30
SP - 224
EP - 228
JO - Revista Espanola de Quimioterapia
JF - Revista Espanola de Quimioterapia
SN - 0214-3429
IS - 3
ER -